Arkolith/Insider Trading/AIKI/Form 4

Yu Soo

DirectorAIkido Pharma Inc. (AIKI) · full profile →Form 4 · filed Sep 14, 2022
Net Buying
Open-Market Buys
$284K
Open-Market Sells
$0
Net Open-Market Flow
$284K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2022Buy(P)45K$6.33$284K53K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-055811) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML